1e
19
1
49
2
2
18
1b
1d
18
3c
8c
1d
2 29
1d
25
Allyson Marie Pishko, MD, MSCE
88
8c
Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
28
78
3
5f
Attending Physician , Hospital of the University of Pennsylvania
86
Associate Program Director for Hematology/Oncology , University of Pennsylvania
11
Department: Medicine
4
1
b
1d
46
Contact information
58
4
3
3
3
2
4
b
1f
58
Hospital of the University of Pennsylvania
1a 3400 Spruce Street
2b 3 Dulles
Philadelphia, PA 19104
26
1a 3400 Spruce Street
2b 3 Dulles
Philadelphia, PA 19104
35
f
13
Education:
21 7 BS c
31 University of Notre Dame, 2008.
21 7 MD 15 (Medicine) c
45 University of Pittsburgh School of Medicine , 2012.
21 9 MSCE 22 (Clinical Epidemiology) c
34 University of Pennsylvania , 2018.
c
3
3
3
3
8d
Permanent link21 7 BS c
31 University of Notre Dame, 2008.
21 7 MD 15 (Medicine) c
45 University of Pittsburgh School of Medicine , 2012.
21 9 MSCE 22 (Clinical Epidemiology) c
34 University of Pennsylvania , 2018.
c
2 29
21
1e
1d
24
5e
26 29
27
Description of Clinical Expertise
78 Clinical expertise in bleeding and thrombotic disorders, including Hereditary Hemorrhagic Telangiectasia26 29
23
157 Yu J, Brown J, Meade J, Gerber GF, Streiff MB, Kraus PS, Merrill SA, Pishko A, Yui JC, Naik RP, Brodsky RA, Lin DD, Chaturvedi S.: Progressive Silent Cerebral Infarction is Associated with Stroke and Persistent Cognitive Impairment in iTTP Survivors. Blood Adv Aug 2025.
b6 Pishko AM, Li A, Cuker A.: Immune Thrombotic Thrombocytopenic Purpura: A Review. JAMA 334: 517-529, Aug 2025.
209 Zakai NA, Wilkinson K, Sparks AD, Packer RT, Roetker NS, Repp AB, Gergi M, Holmes C, Cushman M, Plante TB, Al-Samkari H, Pishko AM, Wood WA, Masias C, Gangaraju R, Li A, Garcia D, Wiggins KL, Schaefer JK, Smith NL, Ferraris A, Martin KA, Terrell DR, McClure LA.: Development and validation of risk models for hospital-acquired bleeding in medical inpatients: the Medical Inpatients Thrombosis and Hemostasis (MITH) study. J Thromb Haemost Jul 2025.
282 Sirotich E, Chowdhury SR, Modi D, Guyatt G, St John M, Eisa K, Cuker A, Beck CE, Grace RF, Yan JW, Ning S, Quinn CT, Pfeiffer A, Lambert MP, Panckeri K, Pishko A, VanAarsen K, Slim A, Carrier K, Geer R, Arulselvan A, Basara M, Cannon B, Bloom EJ, King SJ, Gill D, Venier LM, Xu E, Siddiqui I, Liu B, Mercier T, Buissereth T, Harris EM, Raffa EH, Livingston J, Chowdhury MR, Akbari-Moghaddam M, Kim D, Thabane L, Zeraatkar D, Arnold DM.: Critical bleeding in adults and children with immune thrombocytopenia: a multicenter cohort study. Blood Adv 9: 3238-3248, Jul 2025.
14a Pepin A, Chesnokova A, Pishko A, Gysler S, Martin C, Smith E, Kassick M, Taunk NK.: Hormone Replacement Therapy in Patients with Gynecologic Cancer and Radiation-Induced Premature Ovarian Insufficiency. Int J Radiat Oncol Biol Phys 121: 1042-1052, Mar 2025.
10d JAMA clinical reviews: JAMA Clinical Reviews. Immune Thrombotic Thrombocytopenic Purpura (iTTP). \{JAMA clinical reviews Podcast} 2025 Notes: JAMA clinical reviews Podcast Interview.
1ce Azoulay E, Veyradier A, Cataland S, Joly BS, Knoebl P, Zafrani L, Wendon J, Fakhouri F, Lämmle B, Pavenski K, Biebuyck N, Vanhoorelbeke K, Chaturvedi S, Pishko AM, Donadello K, Scully M, Matsumoto M, Peyvandi F, Mingot-Castellano ME, Zheng XL, Mariotte E, Benhamou Y, Coppo P.: Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025. Intensive Care Med 2025.
218 Al-Samkari H, Kasthuri RS, Mager HJ, Zhou JY, Serra MM, Samuelson-Bannow BT, Van Doren LN, Piccirillo JF, Clancy MS, McCrae KR, Thomas SM, Riera-Mestre A, Pishko AM, Sewaralthahab S, Gossage JR, Iyer VN, Hermans C, Hammill A, Winship I, Mei-Zahav M, von Drygalski A, Olitsky S, Faughnan ME.: Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report. Am J Hematol 2025.
14e Wang LS, Ertmann E, Feldman E, Kossoff M, Lu B, Lin JC, Pishko A, Redfield R, Leonberg-Yoo A, Cuker A.: Utility of Activated Partial Thromboplastin Time Screening in Prospective Living Kidney Donors: A Single Center Cohort Study. Kidney Med 7: 100951, Dec 2024.
2c
7
1d
1f
Selected Publications
167 Zhang E, Kasthuri RS, Parambil J, Prasad V, Iyer V, Whitehead K, Hodges PG, Pishko A, Conrad M, Phelan D, Rodriguez-Lopez J, McCrae KR, Al-Samkari H.: Pomalidomide for Hereditary Hemorrhagic Telangiectasia: After Trial Longitudinal Assessment Study (PATH-HHT ATLAS). Blood Adv Jan 2026.157 Yu J, Brown J, Meade J, Gerber GF, Streiff MB, Kraus PS, Merrill SA, Pishko A, Yui JC, Naik RP, Brodsky RA, Lin DD, Chaturvedi S.: Progressive Silent Cerebral Infarction is Associated with Stroke and Persistent Cognitive Impairment in iTTP Survivors. Blood Adv Aug 2025.
b6 Pishko AM, Li A, Cuker A.: Immune Thrombotic Thrombocytopenic Purpura: A Review. JAMA 334: 517-529, Aug 2025.
209 Zakai NA, Wilkinson K, Sparks AD, Packer RT, Roetker NS, Repp AB, Gergi M, Holmes C, Cushman M, Plante TB, Al-Samkari H, Pishko AM, Wood WA, Masias C, Gangaraju R, Li A, Garcia D, Wiggins KL, Schaefer JK, Smith NL, Ferraris A, Martin KA, Terrell DR, McClure LA.: Development and validation of risk models for hospital-acquired bleeding in medical inpatients: the Medical Inpatients Thrombosis and Hemostasis (MITH) study. J Thromb Haemost Jul 2025.
282 Sirotich E, Chowdhury SR, Modi D, Guyatt G, St John M, Eisa K, Cuker A, Beck CE, Grace RF, Yan JW, Ning S, Quinn CT, Pfeiffer A, Lambert MP, Panckeri K, Pishko A, VanAarsen K, Slim A, Carrier K, Geer R, Arulselvan A, Basara M, Cannon B, Bloom EJ, King SJ, Gill D, Venier LM, Xu E, Siddiqui I, Liu B, Mercier T, Buissereth T, Harris EM, Raffa EH, Livingston J, Chowdhury MR, Akbari-Moghaddam M, Kim D, Thabane L, Zeraatkar D, Arnold DM.: Critical bleeding in adults and children with immune thrombocytopenia: a multicenter cohort study. Blood Adv 9: 3238-3248, Jul 2025.
14a Pepin A, Chesnokova A, Pishko A, Gysler S, Martin C, Smith E, Kassick M, Taunk NK.: Hormone Replacement Therapy in Patients with Gynecologic Cancer and Radiation-Induced Premature Ovarian Insufficiency. Int J Radiat Oncol Biol Phys 121: 1042-1052, Mar 2025.
10d JAMA clinical reviews: JAMA Clinical Reviews. Immune Thrombotic Thrombocytopenic Purpura (iTTP). \{JAMA clinical reviews Podcast} 2025 Notes: JAMA clinical reviews Podcast Interview.
1ce Azoulay E, Veyradier A, Cataland S, Joly BS, Knoebl P, Zafrani L, Wendon J, Fakhouri F, Lämmle B, Pavenski K, Biebuyck N, Vanhoorelbeke K, Chaturvedi S, Pishko AM, Donadello K, Scully M, Matsumoto M, Peyvandi F, Mingot-Castellano ME, Zheng XL, Mariotte E, Benhamou Y, Coppo P.: Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025. Intensive Care Med 2025.
218 Al-Samkari H, Kasthuri RS, Mager HJ, Zhou JY, Serra MM, Samuelson-Bannow BT, Van Doren LN, Piccirillo JF, Clancy MS, McCrae KR, Thomas SM, Riera-Mestre A, Pishko AM, Sewaralthahab S, Gossage JR, Iyer VN, Hermans C, Hammill A, Winship I, Mei-Zahav M, von Drygalski A, Olitsky S, Faughnan ME.: Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report. Am J Hematol 2025.
14e Wang LS, Ertmann E, Feldman E, Kossoff M, Lu B, Lin JC, Pishko A, Redfield R, Leonberg-Yoo A, Cuker A.: Utility of Activated Partial Thromboplastin Time Screening in Prospective Living Kidney Donors: A Single Center Cohort Study. Kidney Med 7: 100951, Dec 2024.
2c